Sanofi (SNY) Gross Profit (2009 - 2026)

Sanofi has disclosed Gross Profit across 18 years of filings, most recently posting $9.5 billion for Q1 2026.

• Gross Profit for Q1 2026 came in at $9.5 billion, up 16.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $39.6 billion (up 24.49% YoY), and the FY2025 annual result was $39.2 billion, up 18.0% from the prior year.
• Gross Profit came in at $9.5 billion for Q1 2026 at Sanofi, up from -$8.2 billion in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $34.7 billion in Q4 2023 to a low of -$8.2 billion in Q4 2025.
• The 5-year median for Gross Profit is $8.1 billion (2025), against an average of $10.2 billion.
• Across the five-year window, Gross Profit surged 339.86% in 2023 and slumped 242.49% in 2025, its largest moves.
• Sanofi's Gross Profit stood at $7.9 billion in 2022, then soared by 339.86% to $34.7 billion in 2023, then slumped by 83.47% to $5.7 billion in 2024, then plunged by 242.49% to -$8.2 billion in 2025, then surged by 216.28% to $9.5 billion in 2026.
• The last three Gross Profit figures came in at $9.5 billion (Q1 2026), -$8.2 billion (Q4 2025), and $29.5 billion (Q3 2025), per Business Quant data.